Tamara Aleksic - Publications

Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma.

Journal: British journal of cancer

Published: August 15, 2019

Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.

Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

Published: December 21, 2018

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.

Journal: Cancer research

Published: November 10, 2017

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.

Journal: British journal of cancer

Published: June 04, 2017

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR.

Journal: Frontiers in oncology

Published: February 15, 2016

IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide.

Journal: Oncotarget

Published: August 19, 2015

IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.

Journal: Carcinogenesis

Published: April 22, 2015

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.

Journal: Cancer research

Published: August 30, 2014

Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.

Journal: International journal of cancer

Published: August 25, 2014

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

Journal: Cancer treatment reviews

Published: March 19, 2014

IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.

Journal: Oncogene

Published: May 19, 2013